Revvity (RVTY) EBIT Growth (5y) (2014 - 2026)
Revvity (RVTY) EBIT Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -30.11% |
| Dec 28, 2025 | -26.19% |
| Sep 28, 2025 | -19.88% |
| Jun 29, 2025 | -12.37% |
| Mar 30, 2025 | 10.08% |
| Dec 29, 2024 | -2.99% |
| Sep 29, 2024 | 4.53% |
| Jun 30, 2024 | -1.35% |
| Mar 31, 2024 | -3.72% |
| Oct 1, 2023 | -2.90% |
| Jul 2, 2023 | -2.38% |
| Apr 2, 2023 | 13.77% |
| Jan 1, 2023 | 7.99% |
| Oct 2, 2022 | 7.26% |
| Jul 3, 2022 | 25.67% |
| Apr 3, 2022 | 39.37% |
| Jan 2, 2022 | 30.11% |
| Oct 3, 2021 | 20.88% |
| Jul 4, 2021 | 35.97% |
| Apr 4, 2021 | 49.67% |